Meet our project team

FT3 Board

The Board leads the program, defining the long and medium-term objectives while respecting internal FT3 principles and rules. It represents the interests of members. The role of the FT3 Board member is voluntary and is not compensated for.

Find out more about the FT3 Governance structure.

Andrea Ferris

President and CEO, LUNGevity Foundation

Begoña Nafría Escalera

Patient Engagement in Research Coordinator, SJD Research Foundation

Dr. Ben Westphalen

Comprehensive Cancer Center Munich

Dr. Durhane Wong-Rieger

President, CORD

Geoffrey Cook

Global Head External & Patient Advocacy, Novartis Oncology

Ivica Belina

President, Koalicija udruga u zdravstvu (KUZ)

Judith Taylor

Co-Director and Secretary, Thyroid Cancer Alliance

Dr. Pooja Merchant

Head Patient Partnerships and Engagement Oncology, Bayer

Ralph Riley

Global Co-Diagnostics Market Access Leader, Janssen

Tanya Knott

Director, Sarah Jennifer Knott Foundation

Dr. Shirlene Badger

Patient Advocacy Lead, Illumina

Sonia Ujupan

Director, Oncology Corporate Affairs, International, Eli Lilly & Company

Susan McClure

Patient Representative

Nicole Sheahan

President, Global Colon Cancer Association

Donatella Decise

Global Director of Patient Engagement Solid Tumors – Lung Cancer, Novartis

James Creeden

Independent Expert

Executive Team

The Executive Committee is responsible for the supervision of the Executive Director and the day-to-day strategic management of the program. With their knowledge and know-how, the Executive Committee provides valuable support for the Executive Director in day-to-day operations and decision-making. The role of the Executive Committee member is voluntary and is not compensated for.